{
 "as_of": "2026-11-06",
 "cmr": "se-cm-kg/SSME/SE0015987904",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Modus Therapeutics Holding AB (First North Sweden: SE0015987904) — research page\n\nAs of 2026-11-06 · se-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Modus Therapeutics Holding AB, listed on First North Sweden under ticker SE0015987904. Its ISIN is SE0015987904 and its LEI is 984500C147FB4EF4A471. The security type, segment, sector and jurisdiction are not on the record. The listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 21 filings across 19 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 10.0 days, and the median for First North Sweden is 11.0 days across 325 issuers. The median latency from the latest filing to the record date is 16 days, against a median of 7 days for the exchange. The sector median is not on the record. The latest filing is an Investor News item dated 2026-10-21. The filings comprise one Annual financial report, nine Company Announcements, one Decisions of general meeting, one Financial statement release, one Half year financial report, two Interim reports (Q1 and Q3), five Investor News items and one Notice to general meeting.\n\n## Auditor\n\nThe auditor of record is not on the record, and its location is not on the record. The market's record does not carry auditor changes for this register.\n\n## Events and halts\n\nThe record does not carry listing, delisting, name change, domicile change or segment move events, because no lifecycle type map exists for this register yet. The halt flag is listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable under the rule version acm-68000/se/mifid-ii-product-governance/r1, as of chapter date 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations page as read.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No sealed years hold the issuer. The live record began on a date not on the record.\n\n## Sources\n\n6 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://firds.esma.europa.eu/firds/ (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.se-cm-kg.ai/events/SSME/SE0015987904 (the disclosure lines)\n- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)\n- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.se-cm-kg.ai/record/SSME/SE0015987904 (the record)\n",
 "market": "SE",
 "node": "se-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the SE vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "SE",
    "state": "not_on_record"
   },
   "changes": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "se-cm-kg/SSME/SE0015987904",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [
    {
     "page": "https://www.modustx.com/investors/analyst-coverage.html",
     "result": "not the issuer's own investor-relations page — not read"
    },
    {
     "page": "https://modustx.com/uploads/pdf_files/MODUS20230705_eng.pdf",
     "result": "an aggregator or news site — not a research note"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 325,
     "median_cadence_gap_days": 11,
     "median_filings": 21,
     "median_latency_days": 7,
     "name": "First North Sweden"
    },
    "sector": {
     "market": "SE",
     "state": "not_on_record"
    }
   },
   "by_type": {
    "Annual financial report": 1,
    "Company Announcement": 9,
    "Decisions of general meeting": 1,
    "Financial statement release": 1,
    "Half year financial report": 1,
    "Interim report (Q1 and Q3)": 2,
    "Investor News": 5,
    "Notice to general meeting": 1
   },
   "cadence_median_gap_days": 10,
   "filing_days": 19,
   "filings": 21,
   "latency_days": 16,
   "latest": [
    {
     "category": "Investor News",
     "date": "2026-10-21",
     "source": "https://view.news.eu.nasdaq.com/view?id=b2074289c6f613cb264241befeb051df0&lang=en&src=listed",
     "title": "Modus Therapeutics: SEVUSMART study of sevuparin in children with severe malaria published in Nature Communications",
     "type": "Investor News"
    },
    {
     "category": "Company Announcement",
     "date": "2026-10-14",
     "source": "https://view.news.eu.nasdaq.com/view?id=bec64b29cc21457b829d2133d41ca3b1c&lang=en&src=listed",
     "title": "Modus Therapeutics temporarily pauses enrollment in Phase IIa study of sevuparin in CKD with anemia",
     "type": "Company Announcement"
    },
    {
     "category": "Company Announcement",
     "date": "2026-09-29",
     "source": "https://view.news.eu.nasdaq.com/view?id=bf4beaec6b9625941566d2d218ad636a2&lang=en&src=listed",
     "title": "Modus announces outcome of the first exercise period for warrants of series TO 2030; receives approximately SEK 134 thousand",
     "type": "Company Announcement"
    },
    {
     "category": "Company Announcement",
     "date": "2026-09-11",
     "source": "https://view.news.eu.nasdaq.com/view?id=b8fbb09ed4db2007abf64b29f4277a72e&lang=en&src=listed",
     "title": "The first exercise period for Modus Therapeutics' warrants of series TO 2030 commences on 14 September 2026",
     "type": "Company Announcement"
    },
    {
     "category": "Company Announcement",
     "date": "2026-09-03",
     "source": "https://view.news.eu.nasdaq.com/view?id=bb2b6cf68d33735a821e26649a5fa6351&lang=en&src=listed",
     "title": "Modus Therapeutics carries out a directed issue of SEK 7.6 million",
     "type": "Company Announcement"
    }
   ],
   "latest_filing_date": "2026-10-21",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.se-cm-kg.ai/events/SSME/SE0015987904",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "First North Sweden"
   },
   "isin": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "SE0015987904"
   },
   "jurisdiction": {
    "market": "SE",
    "state": "not_on_record"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN SE0015987904)",
    "state": "sourced",
    "value": "984500C147FB4EF4A471"
   },
   "name": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "Modus Therapeutics Holding AB"
   },
   "sector": {
    "market": "SE",
    "state": "not_on_record"
   },
   "security_type": {
    "market": "SE",
    "state": "not_on_record"
   },
   "segment": {
    "market": "SE",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "SE0015987904"
   },
   "website": {
    "market": "SE",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "SE",
  "node": "se-cm-kg",
  "numbers_hash": "sha256:33852ac135b89df237b7a273189314579049cd914f16b1172de18a005f22aa45",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://se.eu-cm-kg.ai/book/aio.json",
    "door": "https://se.eu-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/se/mifid-ii-product-governance/r1",
   "section": "se.aio.v5"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.se-cm-kg.ai/record/SSME/SE0015987904",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:33852ac135b89df237b7a273189314579049cd914f16b1172de18a005f22aa45",
 "path": "/se/SSME/SE0015987904",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Modus Therapeutics Holding AB, listed on First North Sweden under ticker SE0015987904. Its ISIN is SE0015987904 and its LEI is 984500C147FB4EF4A471. The security type, segment, sector and jurisdiction are not on the record. The listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 21 filings across 19 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 10.0 days, and the median for First North Sweden is 11.0 days across 325 issuers. The median latency from the latest filing to the record date is 16 days, against a median of 7 days for the exchange. The sector median is not on the record. The latest filing is an Investor News item dated 2026-10-21. The filings comprise one Annual financial report, nine Company Announcements, one Decisions of general meeting, one Financial statement release, one Half year financial report, two Interim reports (Q1 and Q3), five Investor News items and one Notice to general meeting.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is not on the record, and its location is not on the record. The market's record does not carry auditor changes for this register.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record does not carry listing, delisting, name change, domicile change or segment move events, because no lifecycle type map exists for this register yet. The halt flag is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable under the rule version acm-68000/se/mifid-ii-product-governance/r1, as of chapter date 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations page as read.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No sealed years hold the issuer. The live record began on a date not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "6 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://firds.esma.europa.eu/firds/"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.se-cm-kg.ai/events/SSME/SE0015987904"
  },
  {
   "for": "the halt flag",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation"
  },
  {
   "for": "the orderability chapter",
   "source": "https://se.eu-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.se-cm-kg.ai/record/SSME/SE0015987904"
  }
 ],
 "title": "Modus Therapeutics Holding AB (SE0015987904) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}